363 results on '"Minelli R"'
Search Results
52. OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES
- Author
-
Iori, A., primary, cavallaro, L.G., additional, Minelli, R., additional, Merli, R., additional, Nouvenne, A., additional, Maini, A., additional, Morana, E., additional, Guida, L., additional, Curlo, M., additional, Bertelè, A., additional, Cavestro, G.M., additional, Bordi, C., additional, Franzè, A., additional, and Di Mario, F., additional
- Published
- 2008
- Full Text
- View/download PDF
53. Iodine deficiency in schoolchildren of the province of Parma, Italy
- Author
-
Salvi, M., Gardini, E., Minelli, R., Bianconi, L., Pino, S., Braverman, L. E., and Roti, E.
- Published
- 1989
- Full Text
- View/download PDF
54. Thyroid hormone metabolism in obesity
- Author
-
Roti, E, primary, Minelli, R, additional, and Salvi, M, additional
- Published
- 2000
- Full Text
- View/download PDF
55. More Than IL-6 in Graves’ Disease?—Authors’ Response1
- Author
-
Salvi, M., primary, Girasole, G., additional, Pedrazzoni, M., additional, Passeri, M., additional, Giuliani, N., additional, Minelli, R., additional, and Roti, E., additional
- Published
- 1997
- Full Text
- View/download PDF
56. Clinical review 80: Management of hyperthyroidism and hypothyroidism in the pregnant woman.
- Author
-
Roti, E, primary, Minelli, R, additional, and Salvi, M, additional
- Published
- 1996
- Full Text
- View/download PDF
57. The iodine perchlorate discharge test before and after one year of methimazole treatment of hyperthyroid Graves' disease.
- Author
-
Roti, E, primary, Minelli, R, additional, Gardini, E, additional, Bianconi, L, additional, Salvi, M, additional, Gavaruzzi, G, additional, Ugolotti, G, additional, and Braverman, L E, additional
- Published
- 1994
- Full Text
- View/download PDF
58. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
- Author
-
Roti, E, primary, Gardini, E, additional, Minelli, R, additional, Bianconi, L, additional, Salvi, M, additional, Gavaruzzi, G, additional, and Braverman, L E, additional
- Published
- 1993
- Full Text
- View/download PDF
59. Iodine-induced subclinical hypothyroidism in euthyroid subjects with a previous episode of amiodarone-induced thyrotoxicosis.
- Author
-
Roti, E, primary, Minelli, R, additional, Gardini, E, additional, Bianconi, L, additional, Gavaruzzi, G, additional, Ugolotti, G, additional, Neri, T M, additional, and Braverman, L E, additional
- Published
- 1992
- Full Text
- View/download PDF
60. Multiple-diode laser optomechanical issues
- Author
-
Jackson, John E., primary, Armentrout, Ben A., additional, Buck, Jr., J. P., additional, Chenoweth, Amos J., additional, Elliott, G. A., additional, Fox, Allen M., additional, Ganley, Jeff T., additional, Gray, W. C., additional, Jett, Jr., L. L., additional, Johnson, Kevin M., additional, Kelsey, J. F., additional, Minelli, R. J., additional, Rose, Garry E., additional, Shepherd, W. J., additional, and Zino, Joseph D., additional
- Published
- 1991
- Full Text
- View/download PDF
61. Can misdiagnosis in pre-operative FNAC of thyroid nodule influence surgical treatment?
- Author
-
Rio, P., Minelli, R., Cataldo, S., Ceresini, G., Robuschi, G., Corcione, L., Guazzi, A., Nizzoli, R., and Sianesi, M.
- Abstract
Background: Pre-operative cytology in thyroid disease remains the most appropriate diagnostic test for defining the nature of a thyroid nodule before surgical excision. Materials and methods: We selected the most recent 825 surgical thyroid procedures performed in our institution from January 2004 to June 2007; 776 were total thyroidectomies, 23 were lobe-isthmectomies, and 26 were radical neck dissections. We distributed the data based on pre-operative cytology. Each cytological diagnosis was compared to results obtained by definitive histology. Tumors were called incidentalomas if they consisted of a neoplastic focus with a low grade of aggressiveness, as demonstrated by dimension <5 mm, non-aggressive histological subtype. Results: Of the 541 cases of benign disease, 417 were confirmed as benign. The other 124 cases are listed as follows: 29 follicular adenoma; 76 papillary carcinoma (35 found as incidentalomas), and 19 follicular carcinoma (3 incidentalomas). Cytology suggestive of papillary carcinoma was correct in 95.2% of cases (119/125). The 135 tumors termed “follicular neoplasm” were staged on pathology thus: 56 adenoma (41.4%), 26 carcinoma (19.2%), 13 (9.6%) absence of follicular proliferation, 38 (28.1%) papillary follicular variant, 2 (1.4%) undifferentiated cells. Medullary carcinomas were both confirmed. The “suspicious group” exhibited no malignancy on fine needle aspiration cytology (12 of 21; 57%). Conclusions: Cytology has good reliability in malignant lesions. Incidental tumors occurring in benign disease have little impact on clinical and surgical management; “follicular neoplasm” posed two problems — the impossibility of identifying the nature of the tumor, as well as the newer difficulty in distinguishing papillary follicular subtype.
- Published
- 2011
- Full Text
- View/download PDF
62. Is Steroid Therapy Needed in the Treatment of Destructive Thyrotoxicosis Induced by α-Interferon in Chronic Hepatitis C?
- Author
-
Minelli, R., Valli, M.A., Seclì, C. Di, Finardi, L., Chiodera, P., Bertoni, R., Ferrari, C., Barilli, A.L., Coiro, V., Jotti, G. Saccani, and Delsignore, R.
- Abstract
Abstract Objective: Treatment with interferon (IFN) of patients affected by chronic hepatitis C (CH-C) may produce alterations in thyroid function, such as hypothyroidism, Graves-like hyperthyroidism and destructive thyrotoxicosis (DT). IFN-induced DT is characterized by suppressed serum TSH levels, normal or elevated FT4 and FT3 concentrations, with the presence or absence of thyroid peroxidase antibodies and antithyroglobulin antibodies, the absence of thyroid receptor antibodies and radioactive iodine uptake suppressed or <5%. Design: IFN-induced DT is a mild clinical disease, because thyroid-destructive processes last for a short time and involve a small portion of the gland. At present, the therapeutic approach in DT suggests IFN withdrawal and 12 months of methylprednisolone treatment. Methods: In consideration of possible untoward side effects of steroid treatment in patients with CH-C, we studied two groups of patients with CH-C who developed DT after treatments with various preparations of recombinant IFN (with or without ribavirin). Patients sequentially entered the study during a 4-year period, at the time of DT diagnosis, when IFN therapy was discontinued. The first 12 subjects (group A) were treated with 816 mg/day methylprednisolone for 3040 days after IFN withdrawal; in the following 15 patients (group B), IFN withdrawal was not followed by any additional treatment. All patients underwent clinical and laboratory controls of thyroid function at 1, 2, 3 and 6 months after DT diagnosis. Results: The results showed restoration of euthyroidism in both group A and group B patients at 6 months after DT diagnosis, regardless of steroid treatment. Conclusions: The simple withdrawal of IFN therapy in patients with CH-C, who had developed DT, appears to be effective in the treatment of the thyroid disease. This therapeutic approach should be preferred in order to avoid possible undesired side effects of steroid therapy in patients with CH-C.Copyright © 2005 S. Karger AG, Basel- Published
- 2005
63. Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking
- Author
-
Salvi, M, Pedrazzoni, M, Girasole, G, Giuliani, N, Minelli, R, Wall, and Roti, E
- Abstract
OBJECTIVE: In the present study we have measured the concentrations of interleukin-6 (IL-6), soluble IL-6 receptor (sIL-6R), tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta) and IL-1 receptor antagonist (IL-1Ra) in the serum of patients with Graves' disease (GD). By multivariate analysis, we have evaluated the effect of antithyroid treatment, thyroid function, the presence or absence of active thyroid-associated ophthalmopathy (TAO), the patient's smoking habits and the relation to circulating anti-thyrotropin (TSH) receptor (TRAb) and anti-thyroperoxidase antibodies (TPOAb). SUBJECTS: We studied 84 GD patients, 51 untreated and 33 receiving methimazole (MMI) therapy. Twenty-three (45%) untreated patients and 18 (54%) patients on MMI had active TAO. We also studied 67 normal subjects as controls. Thirty-one GD patients (43%) and 16 controls (36%) were smokers. RESULTS: Serum IL-6 concentrations were significantly higher in both untreated patients (P<0.001) and treated patients (P<0.006), when compared with controls. Serum sIL-6R concentrations were significantly affected by treatment (P=0.001). Serum IL-1Ra concentrations were not different in GD patients, whether treated or untreated, compared with controls. Serum IL-6 concentrations were not influenced by thyroid function and there was a significant interaction between treatment and the presence of active TAO (P=0.003). In hyperthyroid patients with active TAO serum, sIL-6R concentrations were significantly higher than in those with inactive TAO (P=0.003). In untreated GD patients there was no significant effect of thyroid function and TAO activity on the serum concentrations of TNF-alpha and IL-1 beta. Serum IL-1Ra concentrations were not affected by the presence of TAO. Smoking had no effect on serum IL-6, sIL-6R, TNF-alpha, IL-1 beta and IL-1Ra concentrations, even in the presence of an active TAO. Serum concentrations of IL-6, sIL-6R, TNF-alpha and IL-1 beta and IL-1Ra were not different in patients with and without TRAb or TPOAb, in relation to either thyroid function, TAO activity or smoking. CONCLUSIONS: Our work shows that: (i) the proinflammatory cytokine pattern in GD is greatly influenced by antithyroid drug treatment; (ii) the increased circulating IL-6/sIL-6R concentrations observed in patients with active TAO may derive from the activation of humoral reactions in sites other than the thyroid; and, (iii) cigarette smoking has no effect on serum IL-1/IL-1Ra concentrations in TAO.
- Published
- 2000
64. Nicotinic and M1-, M2-muscarinic cholinergic control of ACTH response to insulin-induced hypoglycaemia in man
- Author
-
Coiro, V., Passeri, M., Gelmini, G., Davoli, C., Bianconcini, G., Volpi, R., Minelli, R., Delia, P., Fagnoni, F., and Chiodera, P.
- Abstract
Abstract. The possible mediation of muscarinic and/or nicotinic-cholinergic receptors in the response of ACTH to insulin-induced hypoglycaemia was evaluated in 18 normal men. Subjects were tested with the insulin (0.15 U/kg) tolerance test (ITT) in basal conditions and in the presence of the M1- and M2-muscarinic antagonist atropine (600 μg iv just before insulin injection (time 0) plus 600 μg 20 min later in 6 subjects) or the M1-muscarinic receptor blocker pirenzepine (40 mg iv 10 min before ITT or 20 mg at time 0 plus 30 mg at time 20 in 6 subjects). The remaining 6 men were treated with the nicotinic receptor antagonist trimethaphan (0.3 mg/min × 30 min before ITT). ACTH rose 4.7 times in response to hypoglycaemia. The ACTH response to hypoglycaemia did not change after pirenzepine administration, whereas it was significantly increased by atropine and decreased by trimethaphan treatment. These data indicate that nicotinic and muscarinic (M2but not M1) receptors participate in a different manner in the regulation of the hypoglycaemia-induced ACTH release.
- Published
- 1987
- Full Text
- View/download PDF
65. Effects of excess iodine administration on thyroid function in euthyroid patients with a previous episode of thyroid dysfunction induced by interferon-alpha treatment
- Author
-
Minelli, R., Braverman, L.E., Giuberti, T., Schianchi, C., Gardini, E., Salvi, M., Fiaccadori, F., Ugolotti, G., and Roti, E.
- Abstract
OBJECTIVE To determine the effects of pharmacological quantities of iodide (SSKI) on thyroid function in euthyroid patients previously treated with recombinant interferon-alpha (rIFN-alpha) for chronic viral hepatitis B and C (HCV), a cytokine which may induce thyroid dysfunction. DESIGN Thyroid function tests were carried out in 16 euthyroid patients, 8 of whom had previously developed thyroid dysfunction during rIFN-alpha therapy for HCV, before, during and after the administration of 10 drops of saturated solution of potassium iodide (SSKI) (=~350 mg iodide). PATIENTS All 16 patients had been treated in the past with rIFN-alpha for HCV. Eight patients had developed rIFN-alpha induced abnormalities in thyroid function (5 inflammatory thyrotoxicosis, 1 Graves' disease, and 2 impaired thyroid organification of iodide) and 8 had not developed thyroid dysfunction. MEASUREMENTS After baseline serum free T4 (FT4) and free T3 (FT3) concentrations, basal and TRH stimulated TSH concentrations, and TSH-receptor (TSH-R-Ab) and thyroid peroxidase (TPO-Ab) antibodies were measured, 10 drops saturated solution of potassium iodide (SSKI, =~350 mg iodide) were given daily for 60 days and the above parameters assessed during and after SSKI was discontinued. RESULTS Five of 8 patients with a previous history of rIFN-alpha induced thyroid dysfunction developed mild iodide induced abnormalities of thyroid function (subclinical hypothyroidism (slightly elevated basal and TRH stimulated serum TSH concentrations with normal serum FT4 and FT3 concentrations) or hyperthyroidism) compared with the 8 patients who had no previous evidence of thyroid dysfunction during rIFN-alpha therapy. CONCLUSIONS In view of the present observations, it is prudent to avoid the administration of excess iodine to euthyroid subjects with a previous episode of thyroid dysfunction during rIFN-alpha therapy, adding a new group of patients susceptible to iodine induced thyroid disease.
- Published
- 1997
- Full Text
- View/download PDF
66. GERIATRIC-CARDIOLOGY CONFERENCE*.
- Author
-
MINELLI, R., REGGIANI, C., and DE NICOLA, P.
- Abstract
The elastic and mechanical behaviour of isolated papillar muscle was studied in aged and in young rats. The spontaneous fall in tension (stress relaxation phenomenon) and the duration of the active state of the contractile element during the isometric and isotonic contraction were greater in aged than in young rats. The elastic properties of the elements in parallel and in series and the intensity of the active state in the contractile elements, on the contrary, did not exhibit any significant difference between aged and young rats. [ABSTRACT FROM PUBLISHER]
- Published
- 1976
67. In Vitro and In Vivo Therapeutic Evaluation of Camptothecin-Encapsulated β-Cyclodextrin Nanosponges in Prostate Cancer
- Author
-
Casimiro Luca Gigliotti, Minelli R, Cavalli R, Occhipinti S, Barrera G, Pizzimenti S, Cappellano G, Boggio E, Conti L, Fantozzi R, Giovarelli M, Trotta F, Dianzani U, and Dianzani C
68. IMPORTANZA DEGLI ALLERGENI ALIMENTARI, IN RELAZIONE AL RAGGIUNGIMENTO DELLA TOLLERANZA NELLA DERMATITE
- Author
-
Bianchi, E., Pelosi, U., Corona, G. B., Minelli, R., SIMONETTA ORANI, Passeroni, C., Corrias, A., and Corda, R.
69. A rare case of renal tumor in children: Clear cell sarcoma
- Author
-
Brillantino, C., Rossi, E., Minelli, R., Irace, D., Castelli, L., Zeccolini, R., Zeccolini, M., Elio Bignardi, and Tufano, A.
70. Study and parameters identification of a rheological model for excised quiescent cardiac muscle
- Author
-
Capelo, A., primary, Comincioli, V., additional, Minelli, R., additional, Poggesi, C., additional, Reggiani, C., additional, and Ricciardi, L., additional
- Published
- 1981
- Full Text
- View/download PDF
71. The analysis of some mechanical properties of quiescent myocardium
- Author
-
Reggiani, C., primary, Poggesi, C., additional, and Minelli, R., additional
- Published
- 1979
- Full Text
- View/download PDF
72. Effect of Muscarinic and Nicotinic-Cholinergic Blockade on the Glucagon Response to Insulin-Induced Hypoglycemia in Normal Men
- Author
-
Coiro, V., primary, Passeri, M., additional, Volpi, R., additional, Rossi, G., additional, Camellini, L., additional, Davoli, D., additional, Marchesi, M., additional, Muzzetto, P., additional, Minelli, R., additional, Bianconi, L., additional, Coscelli, C., additional, and Chiodera, P., additional
- Published
- 1989
- Full Text
- View/download PDF
73. The relationship between amino acid incorporation and cardiac work level in the rat heart-lung preparation
- Author
-
Minelli, R., primary and Kako, K. J., additional
- Published
- 1969
- Full Text
- View/download PDF
74. Effect of growth hormone and thyroxine on isometric contractile mechanics of cardiac muscle
- Author
-
Minelli, R., primary and Korecky, B., additional
- Published
- 1969
- Full Text
- View/download PDF
75. GERIATRIC-CARDIOLOGY CONFERENCE: MYOCARDIAL CONTRACTILITY IN AGED RATS
- Author
-
MINELLI, R., REGGIANI, C., and DE NICOLA, P.
- Abstract
The elastic and mechanical behaviour of isolated papillar muscle was studied in aged and in young rats. The spontaneous fall in tension (stress relaxation phenomenon) and the duration of the active state of the contractile element during the isometric and isotonic contraction were greater in aged than in young rats. The elastic properties of the elements in parallel and in series and the intensity of the active state in the contractile elements, on the contrary, did not exhibit any significant difference between aged and young rats.
- Published
- 1976
- Full Text
- View/download PDF
76. Methimazole and serum thyroid hormone concentrations in hyperthyroid patients: effects of single and multiple daily doses.
- Author
-
Roti, Elio, Gardini, Eliana, Minelli, Roberta, Salvi, Mario, Robuschi, Giuseppe, Braverman, Lewis E., Roti, E, Gardini, E, Minelli, R, Salvi, M, Robuschi, G, and Braverman, L E
- Subjects
THYROID antagonists ,HYPERTHYROIDISM ,PATIENTS ,COMPARATIVE studies ,DRUG administration ,HEART beat ,LONGITUDINAL method ,RESEARCH methodology ,MEDICAL cooperation ,RESEARCH ,STATISTICAL sampling ,THYROID hormones ,THYROXINE ,TRIIODOTHYRONINE ,EVALUATION research - Abstract
Reports on the effects of single and multiple doses of methimazole on serum thyroxine and heart rate in hyperthyroid patients. Advantages of using single over divided dose of an antithyroid drug; Preference of methimazole to propylthiouracil; Dependence of antithyroid effectiveness of the thionamides on their ability to inhibit the organification of iodine; Percholrate discharge test to evaluate the degree of inhibition.
- Published
- 1989
- Full Text
- View/download PDF
77. Association of a CT-Based Clinical and Radiomics Score of Non-Small Cell Lung Cancer (NSCLC) with Lymph Node Status and Overall Survival
- Author
-
Giovanna Pitoni, Federica Corso, Massimo Bellomi, Stefania Rizzo, Lorenzo Spaggiari, Alessio G. Morganti, Federica Bellerba, Rocco Minelli, Francesca Botta, Filippo Del Grande, Vincenzo Bagnardi, Francesco Petrella, Lisa Rinaldi, Daniela Origgi, Sara Raimondi, Botta, F, Raimondi, S, Rinaldi, L, Bellerba, F, Corso, F, Bagnardi, V, Origgi, D, Minelli, R, Pitoni, G, Petrella, F, Spaggiari, L, Morganti, A, del Grande, F, Bellomi, M, Rizzo, S, Botta F., Raimondi S., Rinaldi L., Bellerba F., Corso F., Bagnardi V., Origgi D., Minelli R., Pitoni G., Petrella F., Spaggiari L., Morganti A.G., del Grande F., Bellomi M., and Rizzo S.
- Subjects
Cancer Research ,medicine.medical_specialty ,overall survival ,non-small cell lung cancer (NSCLC) ,Logistic regression ,lcsh:RC254-282 ,Article ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,Radiomics ,Lasso (statistics) ,computed tomography ,lung cancer ,lymph nodes ,radiomics ,reconstruction algorithms ,Overall survival ,Medicine ,Lung cancer ,Lymph node ,Pathological ,business.industry ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,medicine.disease ,medicine.anatomical_structure ,Oncology ,030220 oncology & carcinogenesis ,Radiology ,Radiomic ,business - Abstract
Background: To evaluate whether a model based on radiomic and clinical features may be associated with lymph node (LN) status and overall survival (OS) in lung cancer (LC) patients; to evaluate whether CT reconstruction algorithms may influence the model performance. Methods: patients operated on for LC with a pathological stage up to T3N1 were retrospectively selected and divided into training and validation sets. For the prediction of positive LNs and OS, the Least Absolute Shrinkage and Selection Operator (LASSO) logistic regression model was used; univariable and multivariable logistic regression analysis assessed the association of clinical-radiomic variables and endpoints. All tests were repeated after dividing the groups according to the CT reconstruction algorithm. p-values < 0.05 were considered significant. Results: 270 patients were included and divided into training (n = 180) and validation sets (n = 90). Transfissural extension was significantly associated with positive LNs. For OS prediction, high- and low-risk groups were different according to the radiomics score, also after dividing the two groups according to reconstruction algorithms. Conclusions: a combined clinical–radiomics model was not superior to a single clinical or single radiomics model to predict positive LNs. A radiomics model was able to separate high-risk and low-risk patients for OS; CTs reconstructed with Iterative Reconstructions (IR) algorithm showed the best model performance.
- Published
- 2020
78. Safety and effectiveness of a somatropin biosimilar in children requiring growth hormone treatment: second analysis of the PATRO Children study Italian cohort
- Author
-
G. Bona, Nella Augusta Greggio, Lorenzo Iughetti, H. Zouater, L. Ragusa, Laura Guazzarotti, P. Fedeli, Gabriella Pozzobon, Claudia Giavoli, P. Gallinari, Franco Antoniazzi, C. Zecchino, Gianluca Tornese, Luca Persani, Stefano Zucchini, Stefano Stagi, Roberta Minelli, Tommaso Aversa, Laura Perrone, Iughetti, L., Antoniazzi, F., Giavoli, C., Bona, G., Aversa, T., Greggio, N. A., Guazzarotti, L., Minelli, R., Perrone, L., Persani, L., Pozzobon, G., Ragusa, L., Stagi, S., Tornese, G., Zecchino, C., Gallinari, P., Zouater, H., Fedeli, P., and Zucchini, S.
- Subjects
Male ,Omnitrope ,Pediatrics ,medicine.medical_specialty ,Abdominal pain ,Adolescent ,Endocrinology, Diabetes and Metabolism ,Recombinant human growth hormone ,030209 endocrinology & metabolism ,® ,Adolescents ,Impaired glucose tolerance ,03 medical and health sciences ,0302 clinical medicine ,Endocrinology ,Product Surveillance, Postmarketing ,medicine ,Clinical endpoint ,Humans ,Children ,Infants ,Pediatric ,Longitudinal Studies ,Child ,Adverse effect ,Biosimilar Pharmaceuticals ,Growth Disorders ,Human Growth Hormone ,business.industry ,Infant ,Prognosis ,medicine.disease ,Growth hormone treatment ,Clinical trial ,030220 oncology & carcinogenesis ,Cohort ,Female ,Observational study ,medicine.symptom ,business ,Follow-Up Studies - Abstract
Purpose: To investigate the long-term safety (primary endpoint) and effectiveness (secondary endpoint) of the somatropin biosimilar Omnitrope®. Methods: PATRO Children is an ongoing, multicenter, observational, post-marketing surveillance study. Children who received Omnitrope® for any indication were included. Adverse events (AEs) were evaluated in all study participants. Auxological data, including height standard deviation scores (HSDS) and height velocity standard deviation scores (HVSDS), were used to assess effectiveness. In this snapshot analysis, data from the Italian subpopulation up to August 2017 were reported. Results: A total of 291 patients (mean age 10.0 years, 56.0% male) were enrolled at 19 sites in Italy. The mean duration of Omnitrope® treatment was 33.1 ± 21.7 months. There were 48 AEs with a suspected relationship to the study drug (as reported by the investigator) that occurred in 35 (12.0%) patients, most commonly headache, pyrexia, arthralgia, insulin-like growth factor above normal range, abdominal pain, pain in extremity and acute gastroenteritis. There were no confirmed cases of type 1 or type 2 diabetes; however, two patients (0.7%) had impaired glucose tolerance that was considered Omnitrope® related. The mean HSDS increased from − 2.41 ± 0.73 at baseline (n = 238) to − 0.91 ± 0.68 at 6.5 years (n = 10). The mean HVSDS increased from − 1.77 ± 1.38 at baseline (n = 136) to 0.96 ± 1.13 at 6.5 years (n = 10). Conclusions: In this sub-analysis of PATRO Children, Omnitrope® appeared to have acceptable safety and effectiveness in the treatment of in Italian children, which was consistent with the earlier findings from controlled clinical trials.
- Published
- 2020
- Full Text
- View/download PDF
79. Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal Adenocarcinoma
- Author
-
Luca Cardone, Alessandro Carugo, Jason B. Fleming, Donatella Del Bufalo, Manuela Iezzi, Gennaro Ciliberto, Giulio Draetta, Justin K. Huang, Daniela Trisciuoglio, Diego Carrella, Michael P. Kim, Davide Melisi, Rosalba Minelli, Diego di Bernardo, Alessia Lamolinara, Christopher A. Bristow, Antonella Iuliano, Simonetta Buglioni, Isabella Manni, Hideo Tomihara, Carla Mottini, Carla Azzurra Amoreo, Frederick S. Robinson, Ya'an Kang, Mottini, C, Tomihara, H, Carrella, D, Lamolinara, A, Iezzi, M, Huang, Jk, Amoreo, Ca, Buglioni, S, Manni, I, Robinson, F, Minelli, R, Kang, Y, Fleming, Jb, Kim, Mp, Bristow, Ca, Trisciuoglio, D, Iuliano, A, Del Bufalo, D, Di Bernardo, D, Melisi, D, Draetta, Gf, Ciliberto, G, Carugo, A, and Cardone, L.
- Subjects
0301 basic medicine ,Drug ,Cancer Research ,endocrine system diseases ,media_common.quotation_subject ,pancreatic cancer ,Decitabine ,Mice, SCID ,Adenocarcinoma ,medicine.disease_cause ,Proto-Oncogene Proteins p21(ras) ,03 medical and health sciences ,Mice ,0302 clinical medicine ,Mice, Inbred NOD ,Pancreatic cancer ,Cell Line, Tumor ,KRAS ,medicine ,Carcinoma ,Animals ,Humans ,neoplasms ,Protein Kinase Inhibitors ,Repurposing ,media_common ,business.industry ,Drug Repositioning ,Gene signature ,medicine.disease ,digestive system diseases ,respiratory tract diseases ,Pancreatic Neoplasms ,030104 developmental biology ,Pyrimidines ,Oncology ,030220 oncology & carcinogenesis ,Cancer cell ,Mutation ,Cancer research ,business ,medicine.drug ,Carcinoma, Pancreatic Ductal ,Signal Transduction - Abstract
Mutated KRAS protein is a pivotal tumor driver in pancreatic cancer. However, despite comprehensive efforts, effective therapeutics that can target oncogenic KRAS are still under investigation or awaiting clinical approval. Using a specific KRAS–dependent gene signature, we implemented a computer-assisted inspection of a drug–gene network to in silico repurpose drugs that work like inhibitors of oncogenic KRAS. We identified and validated decitabine, an FDA-approved drug, as a potent inhibitor of growth in pancreatic cancer cells and patient-derived xenograft models that showed KRAS dependency. Mechanistically, decitabine efficacy was linked to KRAS–driven dependency on nucleotide metabolism and its ability to specifically impair pyrimidine biosynthesis in KRAS–dependent tumors cells. These findings also showed that gene signatures related to KRAS dependency might be prospectively used to inform on decitabine sensitivity in a selected subset of patients with KRAS–mutated pancreatic cancer. Overall, the repurposing of decitabine emerged as an intriguing option for treating pancreatic tumors that are addicted to mutant KRAS, thus offering opportunities for improving the arsenal of therapeutics for this extremely deadly disease. Significance: Decitabine is a promising drug for cancer cells dependent on RAS signaling.
- Published
- 2019
- Full Text
- View/download PDF
80. p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors
- Author
-
Giulio Draetta, Alessandro Sgambato, Prasenjit Dey, Federica Carbone, Melinda Soeung, Sara Loponte, Jose A. Karam, Rosalba Minelli, Nizar M. Tannir, Timothy P. Heffernan, Luigi Sapio, Dolores Lopez-Terrada, Alexander J. Lazar, Ziheng Chen, Alessandro Carugo, Andrea Viale, James Tepper, Priya Rao, Gabriel G. Malouf, Sara Lovisa, Xiaoping Su, Liren Li, Maria Svelto, Edoardo Del Poggetto, Cheryl Walker, Anirban Maitra, Frederick S. Robinson, Dinesh Rakheja, Charles W. M. Roberts, Sanjana Srinivasan, Giannicola Genovese, Samirkumar B. Amin, Francesca Puca, Durga Nand Tripathi, Pavlos Msaouel, George J. Netto, Carugo, A, Minelli, R, Sapio, L, Soeung, M, Carbone, F, Robinson, F, Tepper, J, Chen, Z, Lovisa, S, Svelto, M, Amin, S, Srinivasan, S, Del Poggetto, E, Loponte, S, Puca, F, Dey, P, Malouf, Gg, Su, X, Li, L, Lopez-Terrada, D, Rakheja, D, Lazar, Aj, Netto, Gj, Rao, P, Sgambato, A, Maitra, A, Tripathi, Dn, Walker, Cl, Karam, Ja, Heffernan, Tp, Viale, A, Roberts, Cwm, Msaouel, P, Tannir, Nm, Draetta, Gf, and Genovese, G.
- Subjects
0301 basic medicine ,p53 ,Male ,Cancer Research ,SMARCB1 ,MYC ,medicine.disease_cause ,0302 clinical medicine ,Tumor Cells, Cultured ,Regulation of gene expression ,Mice, Knockout ,BIRC5 ,renal medullary carcinoma ,SMARCB1 Protein ,Endoplasmic Reticulum Stress ,Gene Expression Regulation, Neoplastic ,Oncology ,030220 oncology & carcinogenesis ,Cancer Therapy ,Female ,Signal transduction ,ER stress ,Signal Transduction ,autophagy ,Mice, 129 Strain ,MRT ,rhabdoid tumors ,proteasome inhibitors ,Antineoplastic Agents ,Biology ,Article ,Chromatin remodeling ,embryonic mosaic GEM models ,Proto-Oncogene Proteins c-myc ,03 medical and health sciences ,Settore MED/04 - PATOLOGIA GENERALE ,Cell Line, Tumor ,medicine ,Animals ,Humans ,Cyclin-Dependent Kinase Inhibitor p16 ,Rhabdoid Tumor ,Autophagy ,Mice, Inbred C57BL ,030104 developmental biology ,Proteostasis ,Unfolded protein response ,Cancer research ,Unfolded Protein Response ,Tumor Suppressor Protein p53 ,Carcinogenesis - Abstract
Alterations in chromatin remodeling genes have been increasingly implicated in human oncogenesis. Specifically, the biallelic inactivation of the SWI/SNF subunit SMARCB1 results in the emergence of extremely aggressive pediatric malignancies. Here, we developed embryonic mosaic mouse models of malignant rhabdoid tumors (MRT) that faithfully recapitulate the clinical-pathological features of the human disease. We demonstrated that SMARCB1-deficient malignancies exhibit dramatic activation of the unfolded protein response (UPR) and endoplasmic reticulum (ER) stress response via genetically intact MYC-p19(ARF)-p53 axis. As a consequence, these tumors display an exquisite sensitivity to agents inducing proteotoxic stress and inhibition of the autophagic machinery. In conclusion, our findings provide rationale for drug repositioning trials investigating combinations of agents targeting the UPR and autophagy in SMARCB1-deficient MRT.
- Published
- 2019
81. Coexistence of TSH-secreting pituitary adenoma and autoimmune hypothyroidism
- Author
-
Marco Losa, Roberta Minelli, Massimo Giovanelli, Pietro Mortini, Losa, M, Mortini, Pietro, Minelli, R, and Giovanelli, M.
- Subjects
Adenoma ,Adult ,endocrine system ,medicine.medical_specialty ,endocrine system diseases ,Endocrinology, Diabetes and Metabolism ,media_common.quotation_subject ,Thyrotropin ,Pituitary neoplasm ,Gastroenterology ,Autoimmune Diseases ,Lesion ,Endocrinology ,Hypothyroidism ,Pituitary adenoma ,Internal medicine ,medicine ,Humans ,Pituitary Neoplasms ,Menstruation Disturbances ,Menstrual cycle ,Subclinical infection ,media_common ,medicine.diagnostic_test ,business.industry ,Thyroid ,Magnetic resonance imaging ,medicine.disease ,Thyroxine ,medicine.anatomical_structure ,Female ,medicine.symptom ,business ,hormones, hormone substitutes, and hormone antagonists ,Hormone - Abstract
Objective: TSH-secreting pituitary adenomas account for about 1-2% of all pituitary adenomas. Their diagnosis may be very difficult when coexistence of other diseases masquerades the clinical and biochemical manifestations of TSH-hypersecretion. Clinical presentation: A 41-yr-old female patient, weighing 56 kg, was referred for evaluation of an intra- and suprasellar mass causing menstrual irregularities. Eight yr before, the patient had been given a diagnosis of subclinical autoimmune hypothyroidism because of slightly elevated TSH levels and low-normal free T-4 (FT4). Menses were normal. Despite increasing doses of levo-T-4 (L-T-4; up to 125 mu g/day), TSH levels remained elevated and the patient developed mild symptoms of hyperthyroidism. After 7 yr, the menstrual cycle ceased. Gonadotropins were normal, whereas PRL level was elevated at 70 mu g/l and magnetic resonance imaging (MRI) of the hypothalamic-pituitary region revealed a pituitary lesion with slight suprasellar extension. The tumor was surgically removed and histological examinations revealed a pituitary adenoma strongly positive for TSH. Three months after surgery the patient was well while receiving L-T-4g 75 mu g/day and normal menses had resumed. MRI of the hypothalamic-pituitary region showed no evidence of residual tumor. At the last follow-up, 16 months after surgery, serum TSH, free T-3 (FT3), and FT4 levels were normal. Conclusions: Coexistence of autoimmune hypothyroidism and TSH-secreting pituitary adenoma may cause further delays in the diagnosis of the latter. In patients with autoimmune hypothyroidism, one should be aware of the possible presence of a TSH-secreting pituitary adenoma when TSH levels do not adequately suppress in the face of high doses of L-T-4 replacement therapy and elevated serum thyroid hormone levels.
- Published
- 2006
- Full Text
- View/download PDF
82. B7h triggering inhibits umbilical vascular endothelial cell adhesiveness to tumor cell lines and polymorphonuclear cells
- Author
-
Chiara Sarasso, Chiara Dianzani, Casimiro Luca Gigliotti, Giuseppina Barrera, José M. Rojo, Annalisa Chiocchetti, Junji Yagi, Umberto Dianzani, Sabrina Boscolo, Daniele Sblattero, Rosalba Minelli, Riccardo Mesturini, Roberto Fantozzi, Dianzani, C., Minelli, R., Mesturini, R., Chiocchetti, A., Barrera, G., Boscolo, Sabrina, Sarasso, C., Gigliotti, C. L., Sblattero, Daniele, Yagi, J., Rojo, J. M., Fantozzi, R., and Dianzani, U.
- Subjects
Antigens, Differentiation, T-Lymphocyte ,medicine.drug_class ,Neutrophils ,T cell ,Immunology ,Blotting, Western ,Monoclonal antibody ,B7-H1 Antigen ,Cell Line ,Umbilical Cord ,Inducible T-Cell Co-Stimulator Protein ,CD/immunology ,Antigen ,Antigens, CD ,Cell Line, Tumor ,medicine ,Cell Adhesion ,Immunology and Allergy ,Gene silencing ,Humans ,Osteopontin ,Antigens ,Tumor ,biology ,Cell adhesion molecule ,Endothelial Cells ,Cell biology ,Endothelial stem cell ,medicine.anatomical_structure ,Cell culture ,biology.protein ,Cell Adhesion Molecules ,Signal Transduction - Abstract
Vascular endothelial cells (ECs) are key players in leukocyte recruitment into tissues and metastatic dissemination of tumor cells. ECs express B7h, which is the ligand of the ICOS T cell costimulatory molecule. The aim of this work was to assess the effect of B7h triggering by a soluble form of ICOS (ICOS-Fc) on the adhesion of colon carcinoma cell lines to HUVECs. We found that B7h triggering inhibited HUVEC adhesiveness to HT29 and DLD1 cells (by 50 and 35%, respectively) but not to HCT116 cells. The effect was dependent on the ICOS-Fc dose and was detectable as early as 30 min after treatment and was still present after 24 h. It was inhibited by soluble anti-ICOS reagents (mAb and B7h-Fc) and silencing of B7h on HUVECs, and it was not displayed by an F119S mutated form of ICOS-Fc that does not bind B7h. HUVEC treatment with ICOS-Fc did not modulate expression of adhesion molecules and cytokines, but it substantially downmodulated ERK phosphorylation induced by E-selectin triggering or osteopontin, which may influence HUVEC adhesiveness. Moreover, HUVEC treatment with ICOS-Fc also inhibited adhesion of polymorphonuclear cells and several tumor cell lines from different origins. Therefore, the B7h–ICOS interaction may modulate spreading of cancer metastases and recruitment of polymorphonuclear cells in inflammatory sites, which opens a view on the use of ICOS-Fc as an immunomodulatory drug.
- Published
- 2010
83. Exposure of HL-60 human leukaemic cells to 4-hydroxynonenal promotes the formation of adduct(s) with α-enolase devoid of plasminogen binding activity
- Author
-
Stefania Pizzimenti, Gianfranco Mamone, Fabrizio Gentile, Pasquale Ferranti, Piergiorgio Pettazzoni, Silvestro Formisano, Giuseppina Barrera, Chiara Dianzani, Mario U. Dianzani, Koji Uchida, D D'Angelo, Rosalba Minelli, Gianpaolo Cetrangolo, Alessia Arcaro, Cristina Toaldo, Gentile, F, Pizzimenti, S, Arcaro, A, Pettazzoni, P, Minelli, R, D'Angelo, D, Mamone, G, Ferranti, Pasquale, Toaldo, C, Cetrangolo, G, Formisano, Silvestro, Dianzani, Mu, Uchida, K, Dianzani, C, Barrera, G., F., Gentile, S., Pizzimenti, A., Arcaro, P., Pettazzoni, R., Minelli, D., D'Angelo, G., Mamone, C., Toaldo, G., Cetrangolo, M. U., Dianzani, K., Uchida, C., Dianzani, and G., Barrera
- Subjects
DOWN-REGULATION ,alpha-enolase ,Alpha-enolase ,4-hydroxynonenal (4-HNE) ,plasminogen binding ,PRODUCT ,Biochemistry ,Horseradish peroxidase ,Umbilical vein ,4-Hydroxynonenal ,cell adhesion ,HNE ,HNE adducts ,HL-60 cells ,DNA Adducts ,chemistry.chemical_compound ,C-MYC ,Humans ,plasminogen binding. LIPID-PEROXIDATION ,Cell adhesion ,Receptor ,Molecular Biology ,Cells, Cultured ,GENE-EXPRESSION ,Aldehydes ,Binding Sites ,IDENTIFICATION ,biology ,Chemistry ,Endothelial Cells ,Plasminogen ,MASS-SPECTROMETRY ,Cell Biology ,ENDOTHELIAL-CELLS ,Molecular biology ,PROTEIN-1 MBP-1 ,4-hydroxynonenal adduct ,Cytosol ,DIFFERENTIATION ,Phosphopyruvate Hydratase ,biology.protein ,Human umbilical vein endothelial cell ,HL-60 cell - Abstract
HNE (4-hydroxynonenal), the major product of lipoperoxidation, easily reacts with proteins through adduct formation between its three main functional groups and lysyl, histidyl and cysteinyl residues of proteins. HNE is considered to be an ultimate mediator of toxic effects elicited by oxidative stress. It can be detected in several patho-physiological conditions, in which it affects cellular processes by addition to functional proteins. We demonstrated in the present study, by MS and confirmed by immunoblotting experiments, the formation of HNE–α-enolase adduct(s) in HL-60 human leukaemic cells. α-Enolase is a multifunctional protein that acts as a glycolytic enzyme, transcription factor [MBP-1 ( c -myc binding protein-1)] and plasminogen receptor. HNE did not affect α-enolase enzymatic activity, expression or intracellular localization, and did not change the expression and localization of MBP-1 either. Confocal and electronic microscopy results confirmed the plasma membrane, cytosolic and nuclear localization of α-enolase in HL-60 cells and demonstrated that HNE was colocalized with α-enolase at the surface of cells early after its addition. HNE caused a dose- and time-dependent reduction of the binding of plasminogen to α-enolase. As a consequence, HNE reduced adhesion of HL-60 cells to HUVECs (human umbilical vein endothelial cells). These results could suggest a new role for HNE in the control of tumour growth and invasion. Abbreviations: 2-DE, two-dimensional gel electrophoresis; FCS, fetal calf serum; HNE, 4-hydroxynonenal; HRP, horseradish peroxidase; HUVEC, human umbilical vein endothelial cell; IEF, isoelectrofocusing; LRW, London Resin White; mAb, monoclonal antibody; MALDI–TOF, matrix-assisted laser desorption ionization–time-of-flight; MBP-1, c-myc binding protein-1; PGA, 2-phospho-D-glycerate; TBS, Tris-buffered saline
- Published
- 2009
84. Expulsion of an artificial eye in a patient with thyroid-associated ophthalmopathy and surgical anophthalmos.
- Author
-
Salvi, M, Spaggiari, E, Neri, F, Minelli, R, and Roti, E
- Published
- 1999
85. A case report of hepatic inflammatory myofibroblastic tumor in a pediatric patient: diagnostic challenges and management strategies.
- Author
-
Napolitano M, Lama B, Ierardi AM, Valle C, Rossi E, Minelli R, Paviglianiti G, Di Rosa G, Baldazzi M, and Carrafiello GP
- Abstract
Purpose: The aim of this study is to present a case of inflammatory myofibroblastic tumor (IMT) of the liver in a 4-year-old girl. We will discuss the diagnostic challenges, the role of the radiologist in differential diagnosis, treatment modalities, and clinical outcomes., Methods: A case report of a 4-year-old girl with IMT of the liver is presented. We will review the patient's clinical presentation, diagnostic imaging findings, histological features, treatment, and follow-up., Results: The patient presented with vomiting and jaundice, but no fever. Imaging studies revealed an hepatic lesion suspicious for IMT; pathology confirmed the diagnosis. The patient underwent surgical intervention with successful resolution., Conclusion: IMT of the liver is a rare but important diagnosis to consider in children with abdominal masses. Radiologists play a crucial role in differential diagnosis. Surgical resection can be an effective treatment option for IMT, leading to favorable clinical outcomes., Competing Interests: Declarations. Conflict of interest: The authors have no relevant financial or non-financial interests to disclose. Informed consent: Informed consent was obtained from all individual participants included in the study., (© 2024. Società Italiana di Ultrasonologia in Medicina e Biologia (SIUMB).)
- Published
- 2024
- Full Text
- View/download PDF
86. Atypical clinical and sonographic manifestations of lymphadenopathy in a child with cat-scratch disease: A case report.
- Author
-
Bruni L, Baldazzi M, Greco L, Vivacqua D, Di Vincenzo AO, Corsini I, Bruni S, Minelli R, Rossi E, Paviglianiti G, Napolitano M, Lanari M, and Lovato L
- Subjects
- Humans, Child, Female, Diagnosis, Differential, Cats, Anti-Bacterial Agents therapeutic use, Lymph Nodes diagnostic imaging, Cat-Scratch Disease diagnostic imaging, Lymphadenopathy diagnostic imaging, Lymphadenopathy etiology, Ultrasonography methods, Bartonella henselae
- Abstract
Cat-scratch disease is a well-known infection in childhood. It usually presents as tender lymphadenopathy and should be included in the differential diagnosis of any lymphadenopathy syndrome. An history of exposure to cats supports the suspect and a positive serologic test to Bartonella henselae confirms the diagnosis. Ultrasound is the first line radiologic imaging performed in case of lymphadenopathy. The presence of hypoechoic lobular or oval mass with central hyperaemia and a possible adjacent fluid collection and surrounding oedema may differentiate the disease from other aetiologies. We describe the case of a 7-year-old girl presenting with an axillary lymphadenopathy, without a reported recent history of exposure to cats, with sonographic findings suggestive for cat-scratch disease. In this case, ultrasound was very useful in orienteering the diagnosis and insist on the medical history. Serology resulted positive for B. henselae and at the end the family remembered that 6 months before the child was scratched by a kitten., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
87. Therapeutic modulation of ROCK overcomes metabolic adaptation of cancer cells to OXPHOS inhibition and drives synergistic anti-tumor activity.
- Author
-
Blazanin N, Liang X, Mahmud I, Kim E, Martinez S, Tan L, Chan W, Anvar NE, Ha MJ, Qudratullah M, Minelli R, Peoples M, Lorenzi P, Hart T, and Lissanu Y
- Abstract
Genomic studies have identified frequent mutations in subunits of the SWI/SNF chromatin remodeling complex including SMARCA4 and ARID1A in non-small cell lung cancer. Previously, we and others have identified that SMARCA4 -mutant lung cancers are highly dependent on oxidative phosphorylation (OXPHOS). Despite initial excitements, therapeutics targeting metabolic pathways such as OXPHOS have largely been disappointing due to rapid adaptation of cancer cells to inhibition of single metabolic enzymes or pathways, suggesting novel combination strategies to overcome adaptive responses are urgently needed. Here, we performed a functional genomics screen using CRISPR-Cas9 library targeting genes with available FDA approved therapeutics and identified ROCK1/2 as a top hit that sensitizes cancer cells to OXPHOS inhibition. We validate these results by orthogonal genetic and pharmacologic approaches by demonstrating that KD025 (Belumosudil), an FDA approved ROCK inhibitor, has highly synergistic anti-cancer activity in vitro and in vivo in combination with OXPHOS inhibition. Mechanistically, we showed that this combination induced a rapid, profound energetic stress and cell cycle arrest that was in part due to ROCK inhibition-mediated suppression of the adaptive increase in glycolysis normally seen by OXPHOS inhibition. Furthermore, we applied global phosphoproteomics and kinase-motif enrichment analysis to uncover a dynamic regulatory kinome upon combination of OXPHOS and ROCK inhibition. Importantly, we found converging phosphorylation-dependent regulatory cross-talk by AMPK and ROCK kinases on key RHO GTPase signaling/ROCK-dependent substrates such as PPP1R12A, NUMA1 and PKMYT1 that are known regulators of cell cycle progression. Taken together, our study identified ROCK kinases as critical mediators of metabolic adaptation of cancer cells to OXPHOS inhibition and provides a strong rationale for pursuing ROCK inhibitors as novel combination partners to OXPHOS inhibitors in cancer treatment., Competing Interests: Declaration of Interests Y.L. and N.B. are in the process of filing a patent application of this work.
- Published
- 2024
- Full Text
- View/download PDF
88. Biliary atresia in a 3-month-old infant (case report).
- Author
-
Paviglianiti G, Avallone RC, Cariello V, Vaccaro M, Di Marco F, Minelli R, De Chiara FA, Esposito F, Ferrara D, Rossi A, Pizzicato P, and Rossi E
- Subjects
- Female, Humans, Infant, Liver diagnostic imaging, Liver pathology, Biliary Atresia diagnostic imaging, Biliary Atresia surgery, Biliary Atresia complications, Liver Transplantation, Ultrasonography methods
- Abstract
Biliary atresia (BA) is a congenital disease that occurs when extrahepatic bile ducts are either absent or deficient, resulting in liver fibrosis, portal hypertension, and eventually cirrhosis. It is the most common cause of persistent obstructive jaundice in newborns lasting more than two weeks is this condition. Abdominal ultrasound (US) is the primary imaging technique used to diagnose BA, while computed tomography (CT) is reserved for more complex cases. The gold standard for diagnosing BA is still intraoperative cholangiogram with liver biopsy. Treatment for BA usually involves Kasai hepatoportoenterostomy, but some patients still require liver transplantation due to diagnostic delays and advanced disease. In this study, the authors present the case of a 3-month-old infant with biliary atresia and its ultrasound characteristics, who underwent liver transplantation due to advanced disease. The primary objective of imaging is to provide a prompt diagnosis, given the crucial significance of timely surgical intervention., (© 2024. Società Italiana di Ultrasonologia in Medicina e Biologia (SIUMB).)
- Published
- 2024
- Full Text
- View/download PDF
89. Ultrasound features of cutaneous myiasis: a rare case in a child.
- Author
-
Paviglianiti G, Cariello V, Vaccaro M, Pizzicato P, Minelli R, Di Rosa G, Napolitano M, Baldazzi M, Avallone RC, Rossi A, and Rossi E
- Abstract
Cutaneous myiasis is an infestation of the skin with larvae of some dipteran species. Among humans, Dermatobia hominis is the most frequently encountered dipteran responsible for cutaneous myiasis. This insect is endemic to tropical and subtropical regions, consequently, individuals travelling from non-endemic areas are most susceptible to infection due to a lack of prior exposure. Three clinical variants of myiasis are distinguished: furuncular, migratory, and wound myiasis. Furuncular myiasis represents the most common form among travelers, yet it is a rare cause of pediatric skin manifestations in developed countries. Limited awareness of this condition in non-endemic regions contributes to diagnostic challenges. In this scenario, ultrasound is useful in the diagnostic workup, enabling the identification of the viable larva., (© 2024. Società Italiana di Ultrasonologia in Medicina e Biologia (SIUMB).)
- Published
- 2024
- Full Text
- View/download PDF
90. Testicular juvenile granulosa cell tumor: a case report.
- Author
-
Baldazzi M, Rossi E, Minelli R, Paviglianiti G, Napolitano M, Romeo P, Galuppi F, Di Vincenzo AO, Greco L, Vivacqua D, Thomas E, Lovato L, and Lima M
- Abstract
The Testicular Juvenile Granulosa Cell Tumor (JGCT) is a rare testicular neoplasm that appears in the first months of life as a painless testicular mass. Following an accurate radiological ultrasound diagnosis, through which the cystic appearance of the lesion is observed, and histological confirmation, showing follicular growth pattern and an immunoreactivity for inhibin, the treatment process involves, when feasible, conservative surgery. We present the case of a 2-months old infant with a bilateral JGCT of the testis and we review the classical findings of the patology., (© 2024. Società Italiana di Ultrasonologia in Medicina e Biologia (SIUMB).)
- Published
- 2024
- Full Text
- View/download PDF
91. Congenital tibial pseudarthrosis: A challenge in pediatric radiology.
- Author
-
Cariello V, Smaldone MC, Durante A, Pizzicato P, Rossi A, Minelli R, Ferrara D, Esposito F, Zeccolini M, and Rossi E
- Abstract
Congenital pseudarthrosis of the tibia (CPT) is a rare disorder affecting the skeletal system in pediatric population with an estimated incidence of 1:140,000 to 1:250,000 newborns. It is characterized by deformity of the tibia, including anterolateral bowing of the bone diaphysis and/or narrowing of the medullary canal, leading to instability or fracture. CPT can be either idiopathic or associated with underlying conditions such as type 1 neurofibromatosis (NF1), fibrous dysplasia, or Campanacci's osteofibrous dysplasia. Diagnosis is based on clinical and imaging findings, using conventional radiography and magnetic resonance imaging (MRI). The disorder is characterized by recurrent pathological fractures of the tibia or fibula during childhood, often beginning by the age of 2 years. Treatment options include surgical and nonsurgical management., (© 2024 The Authors. Published by Elsevier Inc. on behalf of University of Washington.)
- Published
- 2024
- Full Text
- View/download PDF
92. Qualitative and quantitative characteristics of CEUS for renal cell carcinoma and angiomyolipoma: a narrative review.
- Author
-
Dipinto P, Canale V, Minelli R, Capuano MA, Catalano O, Di Pierro GB, Anceschi U, Perdonà S, and Tufano A
- Subjects
- Humans, Reproducibility of Results, Carcinoma, Renal Cell diagnostic imaging, Carcinoma, Renal Cell surgery, Angiomyolipoma diagnostic imaging, Angiomyolipoma surgery, Kidney Neoplasms diagnostic imaging, Kidney Neoplasms surgery, Leukemia, Myeloid, Acute
- Abstract
Incidental findings of renal masses are increasing. However, a substantial portion of surgically treated renal masses turn out to be benign on histopathological examination. Thus, there is a clear need for improved pre-surgical assessment to minimize unnecessary invasive procedures. The challenge intensifies when distinguishing between renal cell carcinoma (RCC) and angiomyolipoma (AML) in renal lesions smaller than 4 cm with minimal adipose tissue. In such cases, contrast-enhanced ultrasound (CEUS) has emerged as a valuable diagnostic tool, by utilizing both qualitative and quantitative parameters. Quantitative measures offer objectivity, reliability, and reproducibility compared to qualitative parameters, enabling the characterization of RCC subtypes and differentiation from AML. Qualitative features as enhancement pattern, degree, and peak were less helpful in distinguishing triphasic minimal fat AML (TAML) from epithelioid AML (EAML), with the pseudocapsule sign potentially being the only distinguishing qualitative feature. The pseudocapsule sign was more frequently observed in ccRCCs (38.0%) than in AMLs (15.6%). Moreover, it was detected in 40.0% of EAMLs and 34.5% of ccRCCs but not in TAMLs due to similar growth patterns between EAMLs and low-grade ccRCCs. Quantitative measures such as the time-to-peak (TTP) ratio can further enhance diagnostic accuracy and also TOC ratio should be considered, as it was higher in clear cell RCCs (ccRCCs) and in EAMLs compared to TAMLs, indicating behavior similar to ccRCCs. However, CEUS remains an operator-dependent exam., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
93. Leiomyosarcoma of the inferior vena cava.
- Author
-
Di Pilla MA, Capuano MA, Rossi M, Di Pilla G, Minelli R, Pizzicato P, Rossi A, Paviglianiti G, Irace D, Vallone G, Salvia AAH, Smaldone MC, Cariello V, Zeccolini R, and Rossi E
- Abstract
Inferior vena cava leiomyosarcoma is a rare malignant mesenchymal tumor that originates from the smooth muscle cells of the venous media and is more frequent in females in the V-VI decade of life. Due to scarce and specific symptoms, diagnosis is not simple, and often metastases to the liver, lungs, and/or lymph nodes are already present. A 44-year-old male patient arrives at our institution presenting diffuse abdominal pain and a sense of weight associated with lumbar pain. He showed nothing relevant except for a moderate consumption of alcohol. Ultrasound examination of the abdomen revealed liver enlargement with hyperechoic nodularity and clear margins. Furthermore, the presence of a voluminous solid nodular formation was found, with an inhomogeneous echostructure and moderate vascularization on Doppler. Inferior vena cava leiomyosarcoma is a rare malignancy. The diagnosis is usually established after surgery, however, recurrences are common and the role of chemoradiation therapy remains to be defined. The only potential treatment is surgical resection with possible vessel reconstruction and en bloc removal of adjacent structures with 5 and 10-year survival rates of 49% and 29%, respectively., (© 2023 The Authors. Published by Elsevier Inc. on behalf of University of Washington.)
- Published
- 2023
- Full Text
- View/download PDF
94. Liposarcoma of the spermatic cord: The state of art and our experience.
- Author
-
Di Pilla MA, Capuano MA, Rossi M, Di Pilla G, Minelli R, Pizzicato P, Rossi A, Paviglianiti G, Irace D, Vallone G, Salvia AAH, Smaldone MC, Cariello V, Zeccolini R, and Rossi E
- Abstract
Liposarcoma of the spermatic cord is a malignant neoformation so rare that less than 200 cases are reported in the world. It is a tumor that originates from adipose tissue and when it is found in the spermatic cord it can deceptively simulate an inguinal hernia and not be easily identified. The present work describes the case of a 37-year-old man with liposarcoma of the spermatic cord who arrives at our institution with painless swelling of the left testicle. Physical examination revealed a painless swelling in the scrotal sac. The scrotal ultrasound examination revealed a mass, measuring 8 cm (cranio-caudal) × 5.4 cm (latero-lateral) × 8 cm (antero-posterior) and characterized later with a basal CT examination of the abdomen. The patient was subsequently surgically treated with excision of the tumor, plus hernial plastic with plug and mesh. Histological examination revealed a mature adipocyte neoplasm whose morphological and molecular characteristics (amplification of the MDM2 gene) are consistent with the diagnosis of dediferrentiated liposarcoma variety CO-MINGLED, G2 (sec. FNCLCC) . The patient is currently under cancer surveillance with no signs of loco-regional recurrence. Spermatic cord liposarcoma is an extremely rare malignancy. It's not easy to identify as it can simulate an inguinal hernia, hydrocele, lipoma, funicular cyst, or testicular tumor. Diagnosis is usually established postsurgery, however, relapses are common and the role of chemo-radiotherapy remains to be defined., (© 2023 The Authors.)
- Published
- 2023
- Full Text
- View/download PDF
95. Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancer.
- Author
-
Perelli L, Carbone F, Zhang L, Huang JK, Le C, Khan H, Citron F, Del Poggetto E, Gutschner T, Tomihara H, Soeung M, Minelli R, Srinivasan S, Peoples M, Lam TNA, Lundgren S, Xia R, Zhu C, Mohamed AMT, Zhang J, Sircar K, Sgambato A, Gao J, Jonasch E, Draetta GF, Futreal A, Bakouny Z, Van Allen EM, Choueiri T, Signoretti S, Msaouel P, Litchfield K, Turajlic S, Wang L, Chen YB, Di Natale RG, Hakimi AA, Giuliani V, Heffernan TP, Viale A, Bristow CA, Tannir NM, Carugo A, and Genovese G
- Subjects
- Humans, DNA Copy Number Variations genetics, Chromosomal Instability genetics, Aneuploidy, Carcinoma, Renal Cell genetics, Kidney Neoplasms genetics
- Abstract
Molecular routes to metastatic dissemination are critical determinants of aggressive cancers. Through in vivo CRISPR-Cas9 genome editing, we generated somatic mosaic genetically engineered models that faithfully recapitulate metastatic renal tumors. Disruption of 9p21 locus is an evolutionary driver to systemic disease through the rapid acquisition of complex karyotypes in cancer cells. Cross-species analysis revealed that recurrent patterns of copy number variations, including 21q loss and dysregulation of the interferon pathway, are major drivers of metastatic potential. In vitro and in vivo genomic engineering, leveraging loss-of-function studies, along with a model of partial trisomy of chromosome 21q, demonstrated a dosage-dependent effect of the interferon receptor genes cluster as an adaptive mechanism to deleterious chromosomal instability in metastatic progression. This work provides critical knowledge on drivers of renal cell carcinoma progression and defines the primary role of interferon signaling in constraining the propagation of aneuploid clones in cancer evolution., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
96. SMARCB1 regulates the hypoxic stress response in sickle cell trait.
- Author
-
Soeung M, Perelli L, Chen Z, Dondossola E, Ho IL, Carbone F, Zhang L, Khan H, Le CN, Zhu C, Peoples MD, Feng N, Jiang S, Zacharias NM, Minelli R, Shapiro DD, Deem AK, Gao S, Cheng EH, Lucchetti D, Walker CL, Carugo A, Giuliani V, Heffernan TP, Viale A, Tannir NM, Draetta GF, Msaouel P, and Genovese G
- Subjects
- Animals, Humans, Mice, Hypoxia genetics, Hypoxia metabolism, Kidney metabolism, SMARCB1 Protein genetics, SMARCB1 Protein metabolism, Carcinoma, Renal Cell pathology, Kidney Neoplasms pathology, Sickle Cell Trait genetics, Sickle Cell Trait metabolism
- Abstract
Renal medullary carcinoma (RMC) is an aggressive kidney cancer that almost exclusively develops in individuals with sickle cell trait (SCT) and is always characterized by loss of the tumor suppressor SMARCB1 . Because renal ischemia induced by red blood cell sickling exacerbates chronic renal medullary hypoxia in vivo, we investigated whether the loss of SMARCB1 confers a survival advantage under the setting of SCT. Hypoxic stress, which naturally occurs within the renal medulla, is elevated under the setting of SCT. Our findings showed that hypoxia-induced SMARCB1 degradation protected renal cells from hypoxic stress. SMARCB1 wild-type renal tumors exhibited lower levels of SMARCB1 and more aggressive growth in mice harboring the SCT mutation in human hemoglobin A (HbA) than in control mice harboring wild-type human HbA. Consistent with established clinical observations, SMARCB1-null renal tumors were refractory to hypoxia-inducing therapeutic inhibition of angiogenesis. Further, reconstitution of SMARCB1 restored renal tumor sensitivity to hypoxic stress in vitro and in vivo. Together, our results demonstrate a physiological role for SMARCB1 degradation in response to hypoxic stress, connect the renal medullary hypoxia induced by SCT with an increased risk of SMARCB1-negative RMC, and shed light into the mechanisms mediating the resistance of SMARCB1-null renal tumors against angiogenesis inhibition therapies.
- Published
- 2023
- Full Text
- View/download PDF
97. A rare case of bilateral testicular metastasis from ileocecal NET: multiparametric US detection.
- Author
-
Santarsiere M, Rumolo M, Menna BF, Vergara E, Minelli R, Brillantino C, Rossi E, Brunetti A, and Gisonni P
- Subjects
- Humans, Male, Testicular Neoplasms diagnostic imaging, Testicular Neoplasms secondary, Neuroendocrine Tumors pathology, Ileal Neoplasms pathology
- Abstract
Testicular metastasis are rare findings and bilateral metastasis of testes are extremely rare. Here we are describing for the first time a case of bilateral testicular metastasis in a patient with a known ileocecal valve NET using an in-depth ultra-sound studying including microvascular flow imaging (MV-flow), ultra-sound new technique, able to detect small vessel slow-signal., (© 2022. Società Italiana di Ultrasonologia in Medicina e Biologia (SIUMB).)
- Published
- 2023
- Full Text
- View/download PDF
98. Diagnostic Performance of Contrast-Enhanced Ultrasound in the Evaluation of Small Renal Masses: A Systematic Review and Meta-Analysis.
- Author
-
Tufano A, Antonelli L, Di Pierro GB, Flammia RS, Minelli R, Anceschi U, Leonardo C, Franco G, Drudi FM, and Cantisani V
- Abstract
Ultrasound (US) is a highly sensitive imaging tool in the detection of renal masses. However, the detection rate of small renal masses (SRMs) (<4 cm) is still limited. In this scenario, contrast-enhanced ultrasound (CEUS) is a relatively novel, but increasingly utilized, diagnostic modality which aims to increase the overall diagnostic ability in the identification of SRMs. In consequence, we performed a systematic review (SR) and pooled meta-analysis to investigate the diagnostic performance of CEUS in the evaluation of SRMs confirmed by pathology. A SR up to April 2022 was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. The diagnostic performance of CEUS was evaluated basing on malignant vs. benign SMRs. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) from eligible studies were pooled, and summary receiver operating characteristic (SROC) curves were constructed for each endpoint. Overall, five qualified studies were deemed suitable for this meta-analysis. Finally, diagnostic performance of CEUS showed an accuracy of 0.93 in detecting malignant masses (sensitivity of 0.94, PPV of 0.95, specificity of 0.78, and NPV of 0.73). Taken together, CEUS may represent a promising minimally invasive diagnostic tool for characterization of SMRs, since it allows clinicians to identify malignant lesions.
- Published
- 2022
- Full Text
- View/download PDF
99. Early diagnosis of Meigs syndrome in children A case report and a review of the literature.
- Author
-
Brillantino C, Errico ME, Minelli R, Esposito F, Pirisi P, Gaglione G, Grella MG, Ferrara D, Zeccolini M, and Rossi E
- Subjects
- Female, Child, Humans, Ascites complications, Early Detection of Cancer, Meigs Syndrome diagnosis, Meigs Syndrome complications, Hydrothorax complications, Ovarian Neoplasms, Leiomyoma
- Abstract
Meigs syndrome is a rare disease defined by the coexistence of benign ovarian neoplasm, ascites and hydrothorax, which mainly affects women over the age of 30. This clinical condition refers only to cases in which the ovarian neoformation is a fibroid, a thecoma, a granulosa cell tumor or a Brenner tumor with disappearance of symptoms and effusions after removal of the neoplasm. Meigs syndrome is most frequently characterized by the presence of an ovarian fibroid, which in childhood is very rare and not commonly associated with the disease. In this article we report the case of an 11- year-old girl who came to our observation for a high fever for five days accompanied by cough and abdominal pain; imaging methods revealed bilateral hydrothorax, ascites, and a voluminous expansive right ovarian formation. On histological examination, the mass showed a cellular fibroid and the diagnosis of Meigs syndrome was made. Furthermore, we present a review of the literature aimed at detecting the state of knowledge on this disease in pediatric age, giving particular emphasis to the condition for which, in the presence of pleural effusion and ascites, an ovarian neoformation is not necessarily malignant. KEY WORDS: CT, Meigs syndrome, Pediatric, Pelvic mass, Ultrasounds.
- Published
- 2022
100. Integrated imaging of systemic Langerhans cell histiocytosis in an infant.
- Author
-
Cariello V, Lombardo P, Castelli L, Brillantino C, De Fusco C, Rossi A, Minelli R, Paviglianiti G, Grassi R, and Rossi E
- Abstract
Langerhans cell histiocytosis (LCH) is a myeloid neoplasm characterized by a clonal proliferation of CD1a+/CD207+ dendritic cells. Although individuals of any age can be affected, the disease is most common in infants younger than 5 years of age, especially males. A wide range of manifestations, from asymptomatic to aggressive, have been described, along with multiorgan involvement. Even though the majority of bone lesions are observed, skin, lymph nodes, brain and lungs can also be involved. The involvement of hematopoietic system, including bone marrow, liver and spleen, is less frequent yet associated with worse prognosis, due to a worse treatment response. Diagnosis of LCH is based on the integration of clinical, laboratory, and radiological data; however, only histopathological examination might confirm it. As far as the spleen involvement is concerned, according to literature, it has been reported in about 15% patients with multisystem involvement, nonetheless only a few cases show parenchymal lesions. The present study reports the case of an infant with LCH with multisystem involvement, including bone, skin, liver, and spleen, with evidence of parenchymal lesions., (© 2022 The Authors. Published by Elsevier Inc. on behalf of University of Washington.)
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.